Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study

The International Prognostic Index (IPI) is a widely accepted model that is used to predict the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) who are treated using chemotherapy. However, the prognostic value of the IPI has been a focal point of debate in the immunochemotherapy era...

Descripción completa

Detalles Bibliográficos
Autores principales: HUANG, HONG-HUI, XIAO, FEI, CHEN, FANG-YUAN, WANG, TING, LI, JUN-MIN, WANG, JIAN-MIN, CAO, JUN-NING, WANG, CHUN, ZOU, SHAN-HUA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503699/
https://www.ncbi.nlm.nih.gov/pubmed/23181121
http://dx.doi.org/10.3892/etm.2012.607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503699/
https://www.ncbi.nlm.nih.gov/pubmed/23181121
http://dx.doi.org/10.3892/etm.2012.607

Ejemplares similares